EXPO Exponent Inc

Riverbridge Partners LLC reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 7.7% in Q3 2025, selling 40,146 shares, but still owning 483,015 shares valued at $33.56 million. Other institutional investors adjusted their positions, with overall institutional ownership at 92.37%. CEO Catherine Corrigan also sold 4,930 shares, contributing to total insider sales of 13,055 shares in the past three months.

Assenagon Asset Management S.A. has reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 27.1% in the third quarter of 2025, selling 36,189 shares and retaining 97,573 shares valued at approximately $6.78 million. Exponent posted a strong Q3 performance, beating EPS and revenue estimates, and announced a $100 million share repurchase program and a quarterly dividend. Analyst consensus rates the stock as "Hold" with an average target price of $81.00, despite significant institutional ownership and some insider selling.

UBS has become more optimistic about Exponent's (EXPO) growth prospects for 2026, citing improved demand in Consumer Electronics and planned staff expansion. Despite a rough year for investors, recent share price gains suggest renewed momentum, leading to a narrative that assesses Exponent as potentially undervalued with a fair value near $85.50. However, the article also notes that Exponent's current P/E ratio is significantly higher than its industry average, raising questions about whether positive news is already priced into the stock.

Exponent (NASDAQ:EXPO) CEO Catherine Corrigan sold 3,225 shares of company stock on December 15th for $228,136.50, reducing her stake by 3.69%. This sale is part of a pattern of insider sales this quarter. The company also recently declared a quarterly dividend of $0.30 per share and authorized a $100 million share buyback program.

Shares of scientific consulting firm Exponent (EXPO) rose on December 15, 2025, after UBS increased its price target to $81 from $76, maintaining a "Neutral" rating. The boost followed positive investor meetings with Exponent's management, indicating improving demand, especially in proactive services for Consumer Electronics, and anticipated better revenue in 2026 due to staff growth. Despite the gain, Exponent is down 15.6% year-to-date and 21% below its 52-week high.

Caxton Associates LLP significantly increased its stake in Exponent, Inc. by 305.2% in Q2, bringing its total holdings to 31,686 shares worth $2.37 million. This move is supported by Exponent's solid financial performance, including beating EPS estimates and a 9.6% year-over-year revenue increase, along with ongoing share repurchase programs and a declared quarterly dividend. Other institutional investors have also adjusted their positions in the company, highlighting continued interest in Exponent.